Pharma · Private company
EMD Serono
Track this companyFree. Adds EMD Serono to your Dealase workspace and tells you when its record changes.
Clinical trials257 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- MSC2156119JPhase 1 · Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)NA · RECRUITING · started Feb 25, 2026ClinicalTrials.gov NCT07225660 · fetched Nov 12, 2026
- Avelumab and M1774 in ARID1A-mutated Endometrial CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 14, 2024ClinicalTrials.gov NCT06518564 · fetched Nov 12, 2026
- Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric AssessmentsRECRUITING · started Mar 5, 2024ClinicalTrials.gov NCT06138561 · fetched Nov 12, 2026
- Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck CancerPHASE1 · TERMINATED · started Jan 24, 2024ClinicalTrials.gov NCT06110195 · fetched Nov 12, 2026
- Patient-Centered Care SurveyCOMPLETED · started Oct 23, 2023ClinicalTrials.gov NCT06068634 · fetched Nov 12, 2026
- Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS StudyCOMPLETED · started May 18, 2021ClinicalTrials.gov NCT04754542 · fetched Nov 12, 2026
- Aerobic Exercise for Remyelination in Multiple SclerosisNA · COMPLETED · started Apr 29, 2021ClinicalTrials.gov NCT04539002 · fetched Nov 12, 2026
- Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell CarcinomaPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 8, 2021ClinicalTrials.gov NCT04792073 · fetched Nov 12, 2026
- Cladribine Tablets After Treatment With Natalizumab (CLADRINA)PHASE4 · ACTIVE_NOT_RECRUITING · started Feb 19, 2020ClinicalTrials.gov NCT04178005 · fetched Nov 12, 2026
- Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial CarcinomaPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 17, 2020ClinicalTrials.gov NCT04004442 · fetched Nov 12, 2026
- Validation of a Shared Decision-Making Tool for Multiple SclerosisNA · COMPLETED · started Nov 12, 2019ClinicalTrials.gov NCT04122989 · fetched Nov 12, 2026
- Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple SclerosisPHASE4 · COMPLETED · started Oct 28, 2019ClinicalTrials.gov NCT03963375 · fetched Nov 12, 2026
- Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder CancerPHASE1_PHASE2 · COMPLETED · started May 1, 2019ClinicalTrials.gov NCT03892642 · fetched Nov 12, 2026
- Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPCPHASE2 · TERMINATED · started Jan 25, 2019ClinicalTrials.gov NCT03770455 · fetched Nov 12, 2026
- Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal AdenocarcinomasPHASE2 · COMPLETED · started Jan 24, 2019ClinicalTrials.gov NCT03783936 · fetched Nov 12, 2026
- M6620 (VX-970) in Selected Solid TumorsPHASE2 · COMPLETED · started Jan 8, 2019ClinicalTrials.gov NCT03718091 · fetched Nov 12, 2026
- Avelumab and Radiation in Muscle-Invasive Bladder CancerPHASE2 · TERMINATED · started Dec 13, 2018ClinicalTrials.gov NCT03747419 · fetched Nov 12, 2026
- Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)PHASE1 · COMPLETED · started Jun 21, 2018ClinicalTrials.gov NCT03200587 · fetched Nov 12, 2026
- A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With AvelumabPHASE1_PHASE2 · COMPLETED · started Apr 24, 2018ClinicalTrials.gov NCT03409458 · fetched Nov 12, 2026
- Adjuvant Avelumab in Merkel Cell CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 19, 2017ClinicalTrials.gov NCT03271372 · fetched Nov 12, 2026
- Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by SurgeryPHASE1_PHASE2 · TERMINATED · started Sep 28, 2017ClinicalTrials.gov NCT03074318 · fetched Nov 12, 2026
- Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant GlioblastomaPHASE2 · COMPLETED · started Mar 17, 2017ClinicalTrials.gov NCT02968940 · fetched Nov 12, 2026
- Safety and Efficacy of Avelumab in Small Intestinal AdenocarcinomaPHASE2 · TERMINATED · started Mar 3, 2017ClinicalTrials.gov NCT03000179 · fetched Nov 12, 2026
- Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung CancerPHASE2 · TERMINATED · started Jun 1, 2014ClinicalTrials.gov NCT02093962 · fetched Nov 12, 2026
- First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid TumorsPHASE1 · COMPLETED · started Nov 30, 2009ClinicalTrials.gov NCT01014936 · fetched Nov 12, 2026